Investors

Our investors cover the breadth of experienced entrepreneurs, deep tech, healthcare and growth stage investors.

Cambridge Angels is a group of more than 60 high-net worth investors who have proven experience as successful entrepreneurs in technology, internet, software, hardware, tools and technologies supporting healthcare and digital healthcare. Members invest in and mentor high quality start-up and early-stage companies in these sectors in Cambridge, London, Oxford and throughout the UK.

Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential.

Longwall Ventures invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors.

IQ Capital Partners is a Cambridge based investment fund investing through Seed to Growth. An approachable team that connects with founders from the very first meeting.

BGF, established in 2011 as the Business Growth Fund, is an investment company that provides growth capital for small and mid-sized businesses in the UK and Ireland.

Ananda Impact Ventures is the leading impact-focused venture capital fund with a pan-European investment remit, managing €150 million in four Core Impact Funds, with backing from notable institutional and private investors. Ananda backs technology businesses committed to having a positive impact that answers the most pressing social and ecological challenges of our time, in a way that is both scalable and sustainable.

Meltwind are the due diligence and portfolio management team for Jonathan Milner, founder and former CEO of Abcam. Jonathan invests as an Angel across the life sciences, supporting early-stage companies throughout their journey with investment and guidance.

Downing Ventures invests in innovative technology companies and pioneering founders across the globe with Early to Growth Stage funding across the Deep Tech, Enterprise and Healthcare sectors. The Downing Ventures team spans the UK, USA and Israel giving our portfolio a global perspective and expertise. The team are scientists, engineers, founders, visionary thinkers and story tellers.

LifeArc is a self-funded medical research charity. Our mission is to advance translation of early science into health care treatments or diagnostics that can be fully developed and made available to patients. We have been doing this for more than 25 years and our work has resulted in a diagnostic for antibiotic resistance and four licensed medicines.

Why they chose us

Closed Loop Medicine has established a unique multidisciplinary team developing the next generation of healthcare treatments.

Latest News

Press releases

Closed Loop Medicine closes £13 million to finance its personalised drug + digital therapy (DTx) combination products to improve outcomes for patients through precision dosing.

Press releases

Closed Loop Medicine announces positive outcome of a key clinical drug study required for regulatory submission of its ‘drug plus digital’ insomnia product CLM-IN01.

Press releases

Closed Loop Medicine secures UKCA marking and receives CE designation for a Medical Device that will form part of its insomnia product CLM-IN01

Press releases

Closed Loop Medicine closes £13 million to finance its personalised drug + digital therapy (DTx) combination products to improve outcomes for patients through precision dosing.

Press releases

Closed Loop Medicine announces positive outcome of a key clinical drug study required for regulatory submission of its ‘drug plus digital’ insomnia product CLM-IN01.

Press releases

Closed Loop Medicine secures UKCA marking and receives CE designation for a Medical Device that will form part of its insomnia product CLM-IN01